AVDL
Avadel Pharmaceuticals
AVDL
AVDL
154 hedge funds and large institutions have $1.35B invested in Avadel Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 21 closing their positions.
Holders
154
Holders Change
+27
Holders Change %
+21.26%
% of All Funds
2.24%
Holding in Top 10
8
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-20%
% of All Funds
0.12%
New
50
Increased
45
Reduced
36
Closed
21
Calls
$31.3M
Puts
$10.9M
Net Calls
+$20.4M
Net Calls Change
+$41.3M
Top Buyers
| 1 |
1
AllianceBernstein
Nashville,
Tennessee
|
$322M |
| 2 |
2
BlackRock
New York
|
$67.7M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$51.9M |
| 4 |
TSC
4
Two Seas Capital
Rye,
New York
|
$29.7M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$16M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
JSW
176
Journey Strategic Wealth
Summit,
New Jersey
| – | – | – | – |
|
177
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
178
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
179
Point72 Asset Management
Stamford,
Connecticut
| – | – | – | – |
|
180
T. Rowe Price Associates
Baltimore,
Maryland
| $0 | 29,391 | +29,391 | New |
|